Protocol for establishing CRISPR-Cas12a for efficient genome editing of Pseudomonas aeruginosa phages Authors: Bingjie Yan, Yujia Liu, Yumei Cai, Yuqing Liu, Yibao Chen Published: 2024 ABSTRACT SummaryWe developed an efficient type V CRISPR-Cas12a system tailored specifically for Pseudomonas aeruginosa phages, showcasing its remarkable cleavage activity and the ability to precisely introduce genetic modifications, including point mutations, deletions, and insertions, into phage genomes. Here, we present a protocol for establishing CRISPR-Cas12a for genome editing of Pseudomonas aeruginosa phages. We describe steps for the construction of pCRISPR-12a plasmid and guide RNA and the utilization of the type V CRISPR-Cas12a system for precise genetic editing of phages.For complete details on the use and execution of this protocol, please refer to Chen et al.1 Before you begin This research endeavor aimed to develop an innovative type V CRISPR-Cas12a-based phage editing system for Pseudomonas aeruginosa phages, aiming to address the pressing issue of increasing antibiotic resistance in this bacterium and fill the gap in research on phage genome editing. The CRISPR-Cas12a system was selected for its numerous advantages over CRISPR-Cas9, including a smaller protein size, simplified guide RNA (gRNA) sequence design, and reduced off-target effects, thereby enabling more precise and efficient gene editing.2,3,4 Our study conclusively demonstrated the potent cleavage activity of CRISPR-Cas12a in P. aeruginosa phages, further underscoring its capability to precisely introduce genetic modifications, such as point mutations, deletions, and insertions, into phage genomes. This rapid, efficient, and time-efficient tool is anticipated to transform P. aeruginosa phage engineering, thereby paving the way for the development of more effective treatments for infections caused by this resilient bacterium. The protocol entails introducing the target gRNA sequence derived from the phage genomes, along with approximately 500 bp non-overlapping homologous arm regions flanking the target site, into the pCRISPR-12a plasmid. In cases of gene knock-in, the target gene must be inserted between the left and right homologous arms. Subsequently, along with the pCas12aPA plasmid, they are transformed into engineered bacteria, which then interact with the phage to produce recombinant phages. Further detail of this method can be found in Chen et al.1 Key resources table REAGENT or RESOURCESOURCEIDENTIFIERBacterial and virus strainsE. coli DH5αLaboratory Resource LibraryN/AP. aeruginosa YP25-2Laboratory Resource LibraryN/AP. aeruginosa phage PJNP029Laboratory Resource LibraryGenBank no. OR941787Chemicals, peptides, and recombinant proteinsTetracyclineKlamarCAS:60-54-8CarbenicillinKelamaerCAS: 4800-94-6TryptoneOxoidCAS:LP0042BNaClSangon BiotechCAS:7647-14-5Agar powderSolarbioCAS:9002-18-0StarMarker D2000GenstarCat# ZM022-101L2 × Taq PCR StarMixGenstarCat# A012-10PrimeSTAR Max premix (2 ×)TakaraCat# R045A10 × M bufferTakaraCat# 1093ST4 DNA ligaseThermo Fisher ScientificCat# EL001110 × T4 DNA ligase bufferThermo Fisher ScientificCat# EL0011Xho ITakaraCat# 1094SXba ITakaraCat# 1093SBsaINew England BiolabsCat# M0681SCutSmart bufferNew England BiolabsCat# M0681SYeast extractOxoidCat# LP0021BTris-HClMerckCAS:1185-53-1MgSO4·7H2OChemicalBookCAS:10034-99-8CaCl2MerckCAS:10043-52-4L-arabinoseSolarbioCAS:5328-37-0Critical commercial assaysTIANprep mini plasmid kitTIANGENCat# DP105-02Omega original adhesive recycling kitOmegaCat# D2500-50TClonExpress Ultra one step cloning kitVazymeCat# C116-01Deposited dataRaw and analyzed dataThis paperN/ANCBI databaseGenome Referencehttps://www.ncbi.nlm.nih.gov/genome/OligonucleotidesgRNA-1 forward5′-AGATTGATCTCGGATACCGCTAAGGTC-3′Chen et al.1N/AgRNA-1 reverse5′-GGCCGACCTTAGCGGTATCCGAGATCA-3′Chen et al.1N/AgRNA-2 forward5′-AGATTAAGCCCATCCACTCCGCTTCTG-3′Chen et al.1N/AgRNA-2 reverse5′-GGCCCAGAAGCGGAGTGGATGGGCTTA-3′Chen et al.1N/AgRNA-6 forward5′-AGATCAGTGAATAGCAGTAGGCCCATA-3′Chen et al.1N/AgRNA-6 reverse5′-GGCCTATGGGCCTACTGCTATTCACTG-3′Chen et al.1N/AgRNA-7 forward5′-AGATATTACGCACTGCCAACCACCAAC-3′Chen et al.1N/AgRNA-7 reverse5′-GGCCGTTGGTGGTTGGCAGTGCGTAAT-3′Chen et al.1N/AgRNA-8 forward5′-AGATCGTCTAGAAGACGAGAAGATCGG-3′Chen et al.1N/AgRNA-8 reverse5′-GGCCCCGATCTTCTCGTCTTCTAGACG-3′Chen et al.1N/AYgs2qs-tyb1 primer 15′-GCTCTAGACTCATCCATGGTTGCTAGGTA-3′This paperN/AYgs2qs-tyb1 primer 25′-CTGTGGTATACGACGGCTCCTGTCATTCGTGACGTT-3′This paperN/AYgs2qs-tyb2 primer 15′-AACGTCACGAATGACAGGAGCCGTCGTATACCACAG-3′This paperN/AYgs2qs-tyb2 primer 25′-CCGCTCGAGGTGGATGAAGACTTGCACGGT-3′This paperN/AYgs2dtb-tyb1 primer 15′-GCTCTAGACTTAAACGGTTCTGCAAGGTG-3′This paperN/AYgs2dtb-tyb1 primer 25′-ACGTTATGTGTGACGAACGGTGGGCTCCGC-3′This paperN/AYgs2dtb-tyb2 primer 15′-GCGGAGCCCACCGTTCGTCACACATAACGT-3′This paperN/AYgs2dtb-tyb2 primer 25′-CCGCTCGAGGGCGAGTCGGCTGAAAACTAT-3′This paperN/AYgs2cr-tyb1 primer 15′-TTTTTTGTTTCTGGTCTACCTCTAGACTTAAACGGTTCTGCAAGGTG-3′This paperN/AYgs2cr-tyb1 primer 25′-CCACAAGTTAAAATATAAAACGGTGGGCTCCGC-3′This paperN/AYgs2cr-tyb2 primer 15′-GCGGAGCCCACCGTTTTATATTTTAACTTGTGG-3′This paperN/AYgs2cr-tyb2 primer 25′-CTAAGGAGGTTATAAAAAATGGTTAAAGTAAACGAT-3′This paperN/AYgs2cr-tyb3 primer 15′-ATCGTTTACTTTAACCATTTTTTATAACCTCCTTAG-3′This paperN/AYgs2cr-tyb3 primer 25′-TTCGACGTTATGTGGGACGACTTTTCATACTCCCGCCATTCA-3′This paperN/AYgs2cr-tyb4 primer 15′-TGAATGGCGGGAGTATGAAAAGTCGTCCCACATAACGTCGAA-3′This paperN/AYgs2cr-tyb4 primer 25′-ATGGCGGGAGTATGAAAAGTCTCGAGGGCGAGTCGGCTGAAAACTAT-3′This paperN/Aj-gRNA primer 15′-GCAACTGGTCTATTTTCCTCTTTTG-3′Chen et al.1N/Aj-gRNA primer 25′-CGTCTTCAAGAATTCTGGCAC-3′Chen et al.1N/ARecombinant DNApCRISPR-12aChen et al.1N/ApCas12aPAChen et al.1N/ASoftware and algorithmsCRISPRWebhttp://chopchop.cbu.uib.no/SnapGene v2.3.2Webhttps://www.snapgene.com/Other0.22 μm filterMillexCat# SLGP033RDisposable syringeShuguang JianshiCat#V514993 REAGENT or RESOURCESOURCEIDENTIFIERBacterial and virus strainsE. coli DH5αLaboratory Resource LibraryN/AP. aeruginosa YP25-2Laboratory Resource LibraryN/AP. aeruginosa phage PJNP029Laboratory Resource LibraryGenBank no. OR941787Chemicals, peptides, and recombinant proteinsTetracyclineKlamarCAS:60-54-8CarbenicillinKelamaerCAS: 4800-94-6TryptoneOxoidCAS:LP0042BNaClSangon BiotechCAS:7647-14-5Agar powderSolarbioCAS:9002-18-0StarMarker D2000GenstarCat# ZM022-101L2 × Taq PCR StarMixGenstarCat# A012-10PrimeSTAR Max premix (2 ×)TakaraCat# R045A10 × M bufferTakaraCat# 1093ST4 DNA ligaseThermo Fisher ScientificCat# EL001110 × T4 DNA ligase bufferThermo Fisher ScientificCat# EL0011Xho ITakaraCat# 1094SXba ITakaraCat# 1093SBsaINew England BiolabsCat# M0681SCutSmart bufferNew England BiolabsCat# M0681SYeast extractOxoidCat# LP0021BTris-HClMerckCAS:1185-53-1MgSO4·7H2OChemicalBookCAS:10034-99-8CaCl2MerckCAS:10043-52-4L-arabinoseSolarbioCAS:5328-37-0Critical commercial assaysTIANprep mini plasmid kitTIANGENCat# DP105-02Omega original adhesive recycling kitOmegaCat# D2500-50TClonExpress Ultra one step cloning kitVazymeCat# C116-01Deposited dataRaw and analyzed dataThis paperN/ANCBI databaseGenome Referencehttps://www.ncbi.nlm.nih.gov/genome/OligonucleotidesgRNA-1 forward5′-AGATTGATCTCGGATACCGCTAAGGTC-3′Chen et al.1N/AgRNA-1 reverse5′-GGCCGACCTTAGCGGTATCCGAGATCA-3′Chen et al.1N/AgRNA-2 forward5′-AGATTAAGCCCATCCACTCCGCTTCTG-3′Chen et al.1N/AgRNA-2 reverse5′-GGCCCAGAAGCGGAGTGGATGGGCTTA-3′Chen et al.1N/AgRNA-6 forward5′-AGATCAGTGAATAGCAGTAGGCCCATA-3′Chen et al.1N/AgRNA-6 reverse5′-GGCCTATGGGCCTACTGCTATTCACTG-3′Chen et al.1N/AgRNA-7 forward5′-AGATATTACGCACTGCCAACCACCAAC-3′Chen et al.1N/AgRNA-7 reverse5′-GGCCGTTGGTGGTTGGCAGTGCGTAAT-3′Chen et al.1N/AgRNA-8 forward5′-AGATCGTCTAGAAGACGAGAAGATCGG-3′Chen et al.1N/AgRNA-8 reverse5′-GGCCCCGATCTTCTCGTCTTCTAGACG-3′Chen et al.1N/AYgs2qs-tyb1 primer 15′-GCTCTAGACTCATCCATGGTTGCTAGGTA-3′This paperN/AYgs2qs-tyb1 primer 25′-CTGTGGTATACGACGGCTCCTGTCATTCGTGACGTT-3′This paperN/AYgs2qs-tyb2 primer 15′-AACGTCACGAATGACAGGAGCCGTCGTATACCACAG-3′This paperN/AYgs2qs-tyb2 primer 25′-CCGCTCGAGGTGGATGAAGACTTGCACGGT-3′This paperN/AYgs2dtb-tyb1 primer 15′-GCTCTAGACTTAAACGGTTCTGCAAGGTG-3′This paperN/AYgs2dtb-tyb1 primer 25′-ACGTTATGTGTGACGAACGGTGGGCTCCGC-3′This paperN/AYgs2dtb-tyb2 primer 15′-GCGGAGCCCACCGTTCGTCACACATAACGT-3′This paperN/AYgs2dtb-tyb2 primer 25′-CCGCTCGAGGGCGAGTCGGCTGAAAACTAT-3′This paperN/AYgs2cr-tyb1 primer 15′-TTTTTTGTTTCTGGTCTACCTCTAGACTTAAACGGTTCTGCAAGGTG-3′This paperN/AYgs2cr-tyb1 primer 25′-CCACAAGTTAAAATATAAAACGGTGGGCTCCGC-3′This paperN/AYgs2cr-tyb2 primer 15′-GCGGAGCCCACCGTTTTATATTTTAACTTGTGG-3′This paperN/AYgs2cr-tyb2 primer 25′-CTAAGGAGGTTATAAAAAATGGTTAAAGTAAACGAT-3′This paperN/AYgs2cr-tyb3 primer 15′-ATCGTTTACTTTAACCATTTTTTATAACCTCCTTAG-3′This paperN/AYgs2cr-tyb3 primer 25′-TTCGACGTTATGTGGGACGACTTTTCATACTCCCGCCATTCA-3′This paperN/AYgs2cr-tyb4 primer 15′-TGAATGGCGGGAGTATGAAAAGTCGTCCCACATAACGTCGAA-3′This paperN/AYgs2cr-tyb4 primer 25′-ATGGCGGGAGTATGAAAAGTCTCGAGGGCGAGTCGGCTGAAAACTAT-3′This paperN/Aj-gRNA primer 15′-GCAACTGGTCTATTTTCCTCTTTTG-3′Chen et al.1N/Aj-gRNA primer 25′-CGTCTTCAAGAATTCTGGCAC-3′Chen et al.1N/ARecombinant DNApCRISPR-12aChen et al.1N/ApCas12aPAChen et al.1N/ASoftware and algorithmsCRISPRWebhttp://chopchop.cbu.uib.no/SnapGene v2.3.2Webhttps://www.snapgene.com/Other0.22 μm filterMillexCat# SLGP033RDisposable syringeShuguang JianshiCat#V514993 Materials and equipment Preparation of media and reagent SM buffer: Weigh the following reagents and add ddH2O to dissolve the reagents, autoclave to sterilize (121°C for 20 min)ReagentFinal concentrationVolumeMgSO4·7H2O2.0 g/L2.0 gNaCl5.8 g/L5.8 gTris-HCl pH 7.40.05 mol/L6.057 gddH2ON/A1000 mLTotal1000 mL Note: Store at 20°C–25°C for up to one year. LB liquid medium: Weigh the following reagents and add ddH2O to dissolve the reagents, autoclave to sterilize (121°C for 20 min)ReagentFinal concentrationVolumeTryptone10 g/L10 gNaCl10 g/L10 gYeast extract5 g/L5 gddH2ON/A1000 mLTotal1000 mL Note: Store at 20°C–25°C for up to two months. LB agar for plate: Weigh the following reagents and add ddH2O to dissolve the reagents, autoclave to sterilize (121°C for 20 min)ReagentFinal concentrationVolumeTryptone10 g/L10 gNaCl10 g/L10 gYeast extract5 g/L5 gAgar12 g/L12 gddH2ON/A1000 mLTotal1000 mL Note: Store at 4°C for up to one month. Soft LB: The final concentration of agar is 6 g/L. SM buffer: Weigh the following reagents and add ddH2O to dissolve the reagents, autoclave to sterilize (121°C for 20 min)ReagentFinal concentrationVolumeMgSO4·7H2O2.0 g/L2.0 gNaCl5.8 g/L5.8 gTris-HCl pH 7.40.05 mol/L6.057 gddH2ON/A1000 mLTotal1000 mL SM buffer: Weigh the following reagents and add ddH2O to dissolve the reagents, autoclave to sterilize (121°C for 20 min) Note: Store at 20°C–25°C for up to one year. LB liquid medium: Weigh the following reagents and add ddH2O to dissolve the reagents, autoclave to sterilize (121°C for 20 min)ReagentFinal concentrationVolumeTryptone10 g/L10 gNaCl10 g/L10 gYeast extract5 g/L5 gddH2ON/A1000 mLTotal1000 mL LB liquid medium: Weigh the following reagents and add ddH2O to dissolve the reagents, autoclave to sterilize (121°C for 20 min) Note: Store at 20°C–25°C for up to two months. LB agar for plate: Weigh the following reagents and add ddH2O to dissolve the reagents, autoclave to sterilize (121°C for 20 min)ReagentFinal concentrationVolumeTryptone10 g/L10 gNaCl10 g/L10 gYeast extract5 g/L5 gAgar12 g/L12 gddH2ON/A1000 mLTotal1000 mL LB agar for plate: Weigh the following reagents and add ddH2O to dissolve the reagents, autoclave to sterilize (121°C for 20 min) Note: Store at 4°C for up to one month. Soft LB: The final concentration of agar is 6 g/L. 0.1 M CaCl2 solution: Add 1.098 g CaCl2 to 100 mL of ddH2O, 121°C for 20 min. Store at 4°C for up to 1 year. 150 μg/mL carbenicillin solution: Add 15 mg carbenicillin powder to 100 mL of ddH2O. Then sterilize with a 0.22 μm filter. Store at 4°C for up to 1 month. 100 μg/mL tetracycline solution: Add 10 mg tetracycline powder to 100 mL of ddH2O. Then sterilize with a 0.22 μm filter. Store at 4°C for up to 1 month.Note: Tetracycline solution must be strictly protected from light. Note: Tetracycline solution must be strictly protected from light. 50 mmol/L L-arabinose solution: Add 75 mg L-arabinose powder to 10 mL of ddH2O. Then sterilize with a 0.22 μm filter. Store at 4°C for up to 1 month.CRITICAL: Prepare the solution just before use. CRITICAL: Prepare the solution just before use. Step-by-step method details Construction of recombinant plasmids Timing: 4 days Timing: 4 days This section provides a comprehensive and detailed guide to the process of constructing the pCRISPR-12a-XXX plasmids, specifically tailored to target and efficiently cleave the phage PJNP029.1.Design of pCRISPR-12a-XXX plasmid primers.Note: The design process was conducted utilizing the online resource available at http://chopchop.cbu.uib.no/. Typically, the website will offer a variety of PAM sequences for users to choose from. Specifically, we selected four open reading frames (ORFs) in phage PJNP029 for editing, including essential proteins such as the tail length tape-measure protein (ORF153), ribonucleotide reductase of class Ia (ORF91), a hypothetical protein of unknown function (ORF67), and a distinct phage protein (ORF131). The primer sequences were showed in key resources table.2.Preparation of E. coli DH5a competent cells.a.Retrieve a preserved E. coli DH5a single colony from the −20°C freezer and inoculate it into 3 mL of LB liquid medium.b.Incubate the inoculated medium at 37°C for 12 h with shaking at 200 × g.c.Inoculate the cultured bacterial solution into 50 mL of fresh LB liquid medium at a ratio of 1:100.d.Incubate the inoculated medium at 37°C with shaking at 200 × g for 2.5–3.0 h to allow the bacteria to enter the logarithmic growth phase (OD630nm = 0.6).e.Transfer the cultured product into 1.5 mL centrifuge tubes and centrifuge at 4500 × g for 10 min.f.Add 100 μL (0.1 M) cold CaCl2 solution to suspend the bacterial cells and incubate the suspension on ice for 30 min.g.The prepared competent cells can be stored at −80°C along with glycerol at a total concentration of 25%.3.Synthesis of oligonucleotide with the following reaction system.a.Mix the following reagents to obtain a 10 μL reaction mixture.ReagentsVolume (μL)Upstream oligonucleotide (100 μM)1Downstream oligonucleotide (100 μM)110 ×T4 DNA ligase buffer1Nuclease free water7Total10b.Incubate the reaction mixture at 37°C for 30 min.c.Store at 4°C.4.Construction of plasmid.a.Seamless cloning of the oligonucleotide chain into the pCRISPR-12a-XXX plasmids.b.Mix the following reagents to obtain a 10 μL reaction mixture.ReagentsVolume (μL)10 × T4 DNA ligase buffer1Oligonucleotide (100 ng)1pCRISPR-12a-XXX plasmid (200 ng)1Cutsmart buffer1T4 DNA ligase0.5BsaI0.5Nuclease free water5Total10PCR cycling conditionsStepsTemperatureTimeCycles137°C3 min25216°C4 min380°C15 min410°CForeverNote: All necessary materials for the reaction system should be prepared before the experiment to avoid delaying the experimental process.5.Heat shock transformation.a.Add 10 μL of reaction mixture (recombinant plasmids) to 100 μL of competent E. coli DH5α.b.Place the mixture on ice for 30 min.c.Heat shock at 42°C for 90 s.d.Incubate the mixture on ice for 5 min.e.Add 600 μL of antibiotic-free LB liquid medium to the mixture and incubate it in a shaking incubator at 37°C for 40 min at a speed of 200 × g.f.Spread 100 μL of the mixture onto an LB agar plate containing 150 μg/mL of carbenicillin for 12 h incubation at 37°C.Note: When preparing antibiotic-containing agar plates, it is crucial to add the antibiotic when the temperature of the LB solid medium has cooled to approximately 50°C, in order to avoid compromising the efficacy of the antibiotic due to excessive heat.CRITICAL: The viability of E. coli DH5α in a receptive state is a key factor in improving transformation efficiency.6.Identification of positive transformants.a.Randomly pick 2–3 single colonies and then inoculate them into 3 mL of LB liquid medium with the corresponding antibiotic.b.Incubate the cultures at 37°C for 12 h in a shaking incubator at 200 × g for 12 h.c.Perform PCR amplification using the verification primer j-gRNA primers.d.Mix the following reagents to obtain a 20 μL reaction mixture.ReagentsVolume (μL)2 × Taq PCR StarMix10j-gRNA primer 10.5j-gRNA primer 20.5Template DNA (10 ng)2Nuclease free water7Total20PCR cycling conditionsStepsTemperatureTimeCyclesDenaturation94°C30 s30Annealing52°C30 sExtension72°C45 sHold4°CForeverNote: The extension time depends on the PCR product size; i.e., approximately <1 kb, 10 sec; 1–3 kb, 10–20 sec/kb.e.Extract plasmids using the TIANprep Mini Plasmid Kit (TIANGEN, Tianjing, China), following the specific steps outlined in the instruction manual. Store the extracted recombinant plasmid at −20°C.Pause point: The constructed recombinant plasmid was stored at −20°C until needed. 1.Design of pCRISPR-12a-XXX plasmid primers. Design of pCRISPR-12a-XXX plasmid primers. Note: The design process was conducted utilizing the online resource available at http://chopchop.cbu.uib.no/. Typically, the website will offer a variety of PAM sequences for users to choose from. Specifically, we selected four open reading frames (ORFs) in phage PJNP029 for editing, including essential proteins such as the tail length tape-measure protein (ORF153), ribonucleotide reductase of class Ia (ORF91), a hypothetical protein of unknown function (ORF67), and a distinct phage protein (ORF131). The primer sequences were showed in key resources table. 2.Preparation of E. coli DH5a competent cells.a.Retrieve a preserved E. coli DH5a single colony from the −20°C freezer and inoculate it into 3 mL of LB liquid medium.b.Incubate the inoculated medium at 37°C for 12 h with shaking at 200 × g.c.Inoculate the cultured bacterial solution into 50 mL of fresh LB liquid medium at a ratio of 1:100.d.Incubate the inoculated medium at 37°C with shaking at 200 × g for 2.5–3.0 h to allow the bacteria to enter the logarithmic growth phase (OD630nm = 0.6).e.Transfer the cultured product into 1.5 mL centrifuge tubes and centrifuge at 4500 × g for 10 min.f.Add 100 μL (0.1 M) cold CaCl2 solution to suspend the bacterial cells and incubate the suspension on ice for 30 min.g.The prepared competent cells can be stored at −80°C along with glycerol at a total concentration of 25%. Preparation of E. coli DH5a competent cells.a.Retrieve a preserved E. coli DH5a single colony from the −20°C freezer and inoculate it into 3 mL of LB liquid medium.b.Incubate the inoculated medium at 37°C for 12 h with shaking at 200 × g.c.Inoculate the cultured bacterial solution into 50 mL of fresh LB liquid medium at a ratio of 1:100.d.Incubate the inoculated medium at 37°C with shaking at 200 × g for 2.5–3.0 h to allow the bacteria to enter the logarithmic growth phase (OD630nm = 0.6).e.Transfer the cultured product into 1.5 mL centrifuge tubes and centrifuge at 4500 × g for 10 min.f.Add 100 μL (0.1 M) cold CaCl2 solution to suspend the bacterial cells and incubate the suspension on ice for 30 min.g.The prepared competent cells can be stored at −80°C along with glycerol at a total concentration of 25%. a.Retrieve a preserved E. coli DH5a single colony from the −20°C freezer and inoculate it into 3 mL of LB liquid medium. Retrieve a preserved E. coli DH5a single colony from the −20°C freezer and inoculate it into 3 mL of LB liquid medium. b.Incubate the inoculated medium at 37°C for 12 h with shaking at 200 × g. Incubate the inoculated medium at 37°C for 12 h with shaking at 200 × g. c.Inoculate the cultured bacterial solution into 50 mL of fresh LB liquid medium at a ratio of 1:100. Inoculate the cultured bacterial solution into 50 mL of fresh LB liquid medium at a ratio of 1:100. d.Incubate the inoculated medium at 37°C with shaking at 200 × g for 2.5–3.0 h to allow the bacteria to enter the logarithmic growth phase (OD630nm = 0.6). Incubate the inoculated medium at 37°C with shaking at 200 × g for 2.5–3.0 h to allow the bacteria to enter the logarithmic growth phase (OD630nm = 0.6). e.Transfer the cultured product into 1.5 mL centrifuge tubes and centrifuge at 4500 × g for 10 min. Transfer the cultured product into 1.5 mL centrifuge tubes and centrifuge at 4500 × g for 10 min. f.Add 100 μL (0.1 M) cold CaCl2 solution to suspend the bacterial cells and incubate the suspension on ice for 30 min. Add 100 μL (0.1 M) cold CaCl2 solution to suspend the bacterial cells and incubate the suspension on ice for 30 min. g.The prepared competent cells can be stored at −80°C along with glycerol at a total concentration of 25%. The prepared competent cells can be stored at −80°C along with glycerol at a total concentration of 25%. 3.Synthesis of oligonucleotide with the following reaction system.a.Mix the following reagents to obtain a 10 μL reaction mixture.ReagentsVolume (μL)Upstream oligonucleotide (100 μM)1Downstream oligonucleotide (100 μM)110 ×T4 DNA ligase buffer1Nuclease free water7Total10b.Incubate the reaction mixture at 37°C for 30 min.c.Store at 4°C. Synthesis of oligonucleotide with the following reaction system.a.Mix the following reagents to obtain a 10 μL reaction mixture.ReagentsVolume (μL)Upstream oligonucleotide (100 μM)1Downstream oligonucleotide (100 μM)110 ×T4 DNA ligase buffer1Nuclease free water7Total10b.Incubate the reaction mixture at 37°C for 30 min.c.Store at 4°C. a.Mix the following reagents to obtain a 10 μL reaction mixture.ReagentsVolume (μL)Upstream oligonucleotide (100 μM)1Downstream oligonucleotide (100 μM)110 ×T4 DNA ligase buffer1Nuclease free water7Total10 Mix the following reagents to obtain a 10 μL reaction mixture.ReagentsVolume (μL)Upstream oligonucleotide (100 μM)1Downstream oligonucleotide (100 μM)110 ×T4 DNA ligase buffer1Nuclease free water7Total10 ReagentsVolume (μL)Upstream oligonucleotide (100 μM)1Downstream oligonucleotide (100 μM)110 ×T4 DNA ligase buffer1Nuclease free water7Total10 b.Incubate the reaction mixture at 37°C for 30 min. Incubate the reaction mixture at 37°C for 30 min. c.Store at 4°C. Store at 4°C. 4.Construction of plasmid.a.Seamless cloning of the oligonucleotide chain into the pCRISPR-12a-XXX plasmids.b.Mix the following reagents to obtain a 10 μL reaction mixture. Construction of plasmid.a.Seamless cloning of the oligonucleotide chain into the pCRISPR-12a-XXX plasmids.b.Mix the following reagents to obtain a 10 μL reaction mixture. a.Seamless cloning of the oligonucleotide chain into the pCRISPR-12a-XXX plasmids. Seamless cloning of the oligonucleotide chain into the pCRISPR-12a-XXX plasmids. b.Mix the following reagents to obtain a 10 μL reaction mixture. Mix the following reagents to obtain a 10 μL reaction mixture. ReagentsVolume (μL)10 × T4 DNA ligase buffer1Oligonucleotide (100 ng)1pCRISPR-12a-XXX plasmid (200 ng)1Cutsmart buffer1T4 DNA ligase0.5BsaI0.5Nuclease free water5Total10 PCR cycling conditionsStepsTemperatureTimeCycles137°C3 min25216°C4 min380°C15 min410°CForever Note: All necessary materials for the reaction system should be prepared before the experiment to avoid delaying the experimental process. 5.Heat shock transformation.a.Add 10 μL of reaction mixture (recombinant plasmids) to 100 μL of competent E. coli DH5α.b.Place the mixture on ice for 30 min.c.Heat shock at 42°C for 90 s.d.Incubate the mixture on ice for 5 min.e.Add 600 μL of antibiotic-free LB liquid medium to the mixture and incubate it in a shaking incubator at 37°C for 40 min at a speed of 200 × g.f.Spread 100 μL of the mixture onto an LB agar plate containing 150 μg/mL of carbenicillin for 12 h incubation at 37°C. Heat shock transformation.a.Add 10 μL of reaction mixture (recombinant plasmids) to 100 μL of competent E. coli DH5α.b.Place the mixture on ice for 30 min.c.Heat shock at 42°C for 90 s.d.Incubate the mixture on ice for 5 min.e.Add 600 μL of antibiotic-free LB liquid medium to the mixture and incubate it in a shaking incubator at 37°C for 40 min at a speed of 200 × g.f.Spread 100 μL of the mixture onto an LB agar plate containing 150 μg/mL of carbenicillin for 12 h incubation at 37°C. a.Add 10 μL of reaction mixture (recombinant plasmids) to 100 μL of competent E. coli DH5α. Add 10 μL of reaction mixture (recombinant plasmids) to 100 μL of competent E. coli DH5α. b.Place the mixture on ice for 30 min. Place the mixture on ice for 30 min. c.Heat shock at 42°C for 90 s. Heat shock at 42°C for 90 s. d.Incubate the mixture on ice for 5 min. Incubate the mixture on ice for 5 min. e.Add 600 μL of antibiotic-free LB liquid medium to the mixture and incubate it in a shaking incubator at 37°C for 40 min at a speed of 200 × g. Add 600 μL of antibiotic-free LB liquid medium to the mixture and incubate it in a shaking incubator at 37°C for 40 min at a speed of 200 × g. f.Spread 100 μL of the mixture onto an LB agar plate containing 150 μg/mL of carbenicillin for 12 h incubation at 37°C. Spread 100 μL of the mixture onto an LB agar plate containing 150 μg/mL of carbenicillin for 12 h incubation at 37°C. Note: When preparing antibiotic-containing agar plates, it is crucial to add the antibiotic when the temperature of the LB solid medium has cooled to approximately 50°C, in order to avoid compromising the efficacy of the antibiotic due to excessive heat. CRITICAL: The viability of E. coli DH5α in a receptive state is a key factor in improving transformation efficiency. 6.Identification of positive transformants.a.Randomly pick 2–3 single colonies and then inoculate them into 3 mL of LB liquid medium with the corresponding antibiotic.b.Incubate the cultures at 37°C for 12 h in a shaking incubator at 200 × g for 12 h.c.Perform PCR amplification using the verification primer j-gRNA primers.d.Mix the following reagents to obtain a 20 μL reaction mixture.ReagentsVolume (μL)2 × Taq PCR StarMix10j-gRNA primer 10.5j-gRNA primer 20.5Template DNA (10 ng)2Nuclease free water7Total20PCR cycling conditionsStepsTemperatureTimeCyclesDenaturation94°C30 s30Annealing52°C30 sExtension72°C45 sHold4°CForeverNote: The extension time depends on the PCR product size; i.e., approximately <1 kb, 10 sec; 1–3 kb, 10–20 sec/kb.e.Extract plasmids using the TIANprep Mini Plasmid Kit (TIANGEN, Tianjing, China), following the specific steps outlined in the instruction manual. Store the extracted recombinant plasmid at −20°C.Pause point: The constructed recombinant plasmid was stored at −20°C until needed. Identification of positive transformants.a.Randomly pick 2–3 single colonies and then inoculate them into 3 mL of LB liquid medium with the corresponding antibiotic.b.Incubate the cultures at 37°C for 12 h in a shaking incubator at 200 × g for 12 h.c.Perform PCR amplification using the verification primer j-gRNA primers.d.Mix the following reagents to obtain a 20 μL reaction mixture.ReagentsVolume (μL)2 × Taq PCR StarMix10j-gRNA primer 10.5j-gRNA primer 20.5Template DNA (10 ng)2Nuclease free water7Total20PCR cycling conditionsStepsTemperatureTimeCyclesDenaturation94°C30 s30Annealing52°C30 sExtension72°C45 sHold4°CForeverNote: The extension time depends on the PCR product size; i.e., approximately <1 kb, 10 sec; 1–3 kb, 10–20 sec/kb.e.Extract plasmids using the TIANprep Mini Plasmid Kit (TIANGEN, Tianjing, China), following the specific steps outlined in the instruction manual. Store the extracted recombinant plasmid at −20°C.Pause point: The constructed recombinant plasmid was stored at −20°C until needed. a.Randomly pick 2–3 single colonies and then inoculate them into 3 mL of LB liquid medium with the corresponding antibiotic. Randomly pick 2–3 single colonies and then inoculate them into 3 mL of LB liquid medium with the corresponding antibiotic. b.Incubate the cultures at 37°C for 12 h in a shaking incubator at 200 × g for 12 h. Incubate the cultures at 37°C for 12 h in a shaking incubator at 200 × g for 12 h. c.Perform PCR amplification using the verification primer j-gRNA primers. Perform PCR amplification using the verification primer j-gRNA primers. d.Mix the following reagents to obtain a 20 μL reaction mixture.ReagentsVolume (μL)2 × Taq PCR StarMix10j-gRNA primer 10.5j-gRNA primer 20.5Template DNA (10 ng)2Nuclease free water7Total20PCR cycling conditionsStepsTemperatureTimeCyclesDenaturation94°C30 s30Annealing52°C30 sExtension72°C45 sHold4°CForeverNote: The extension time depends on the PCR product size; i.e., approximately <1 kb, 10 sec; 1–3 kb, 10–20 sec/kb. Mix the following reagents to obtain a 20 μL reaction mixture.ReagentsVolume (μL)2 × Taq PCR StarMix10j-gRNA primer 10.5j-gRNA primer 20.5Template DNA (10 ng)2Nuclease free water7Total20PCR cycling conditionsStepsTemperatureTimeCyclesDenaturation94°C30 s30Annealing52°C30 sExtension72°C45 sHold4°CForeverNote: The extension time depends on the PCR product size; i.e., approximately <1 kb, 10 sec; 1–3 kb, 10–20 sec/kb. ReagentsVolume (μL)2 × Taq PCR StarMix10j-gRNA primer 10.5j-gRNA primer 20.5Template DNA (10 ng)2Nuclease free water7Total20 PCR cycling conditionsStepsTemperatureTimeCyclesDenaturation94°C30 s30Annealing52°C30 sExtension72°C45 sHold4°CForever Note: The extension time depends on the PCR product size; i.e., approximately <1 kb, 10 sec; 1–3 kb, 10–20 sec/kb. e.Extract plasmids using the TIANprep Mini Plasmid Kit (TIANGEN, Tianjing, China), following the specific steps outlined in the instruction manual. Store the extracted recombinant plasmid at −20°C.Pause point: The constructed recombinant plasmid was stored at −20°C until needed. Extract plasmids using the TIANprep Mini Plasmid Kit (TIANGEN, Tianjing, China), following the specific steps outlined in the instruction manual. Store the extracted recombinant plasmid at −20°C.Pause point: The constructed recombinant plasmid was stored at −20°C until needed. Pause point: The constructed recombinant plasmid was stored at −20°C until needed. Transformation of P. aeruginosa YP25-2 Timing: 3 days Timing: 3 days This section outlines the detailed process of transforming the plasmids pCRISPR-12a-XXX and pCas12aPA into the engineered bacteria.7.Preparation of P. aeruginosa YP25-2 competent cells.a.Inoculate a single colony of P. aeruginosa YP25-2 into 3 mL of LB liquid medium and incubate at 37°C for 12 h with shaking at 200 × g.b.Transfer the culture at a ratio of 1:100 into 50 mL of LB liquid medium.c.Incubate at 37°C with shaking at 200 × g for 2.5–3.0 h to allow the bacteria to enter the logarithmic growth phase (OD630nm = 0.6).d.Dispense the bacteria into 1.5 mL centrifuge tubes and centrifuge them at 4 °C at 7,000 × g for 5 min, followed by discarding the supernatant.e.Resuspend the bacteria in 750 μL of sterile ddH2O and centrifuge again at 4 °C at 7,000 × g for 5 min, followed by discarding the supernatant. This process was repeated three times.f.Store the competent cells of P. aeruginosa YP25-2 at −80°C along with glycerol at a total concentration of 25%.Note: Strict control of temperature and rotation speed is imperative during this process to ensure optimal bacterial growth and transformation efficiency. Furthermore, the prepared competent cells must be stored appropriately to prevent contamination and maintain their effectiveness.8.Electroporation of pCas12aPA and pCRISPR-12a-XXX plasmids into P. aeruginosa YP25-2.a.Add 200 ng of pCasPA-12a plasmid and 200 ng of pCRISPR-12a-XXX plasmid to the 100 μL of P. aeruginosa competent cells prepared above (step 7).b.Transfer the competent cells to a 0.1 mm diameter electroporation cuvette (2100 V, 100 Ω, and 25 μF).c.After electroporation, add 600 μL of antibiotic-free LB liquid medium and incubate on a shaking incubator at 37°C for 2 h.d.Spread 100 μL of the mixture on an LB plate containing 150 μg/mL carbenicillin and 100 μg/mL tetracycline.Note: When transferring plasmid DNA into competent cells, ensure that the maximum volume of competent cells does not exceed 200 μL. 7.Preparation of P. aeruginosa YP25-2 competent cells.a.Inoculate a single colony of P. aeruginosa YP25-2 into 3 mL of LB liquid medium and incubate at 37°C for 12 h with shaking at 200 × g.b.Transfer the culture at a ratio of 1:100 into 50 mL of LB liquid medium.c.Incubate at 37°C with shaking at 200 × g for 2.5–3.0 h to allow the bacteria to enter the logarithmic growth phase (OD630nm = 0.6).d.Dispense the bacteria into 1.5 mL centrifuge tubes and centrifuge them at 4 °C at 7,000 × g for 5 min, followed by discarding the supernatant.e.Resuspend the bacteria in 750 μL of sterile ddH2O and centrifuge again at 4 °C at 7,000 × g for 5 min, followed by discarding the supernatant. This process was repeated three times.f.Store the competent cells of P. aeruginosa YP25-2 at −80°C along with glycerol at a total concentration of 25%. Preparation of P. aeruginosa YP25-2 competent cells.a.Inoculate a single colony of P. aeruginosa YP25-2 into 3 mL of LB liquid medium and incubate at 37°C for 12 h with shaking at 200 × g.b.Transfer the culture at a ratio of 1:100 into 50 mL of LB liquid medium.c.Incubate at 37°C with shaking at 200 × g for 2.5–3.0 h to allow the bacteria to enter the logarithmic growth phase (OD630nm = 0.6).d.Dispense the bacteria into 1.5 mL centrifuge tubes and centrifuge them at 4 °C at 7,000 × g for 5 min, followed by discarding the supernatant.e.Resuspend the bacteria in 750 μL of sterile ddH2O and centrifuge again at 4 °C at 7,000 × g for 5 min, followed by discarding the supernatant. This process was repeated three times.f.Store the competent cells of P. aeruginosa YP25-2 at −80°C along with glycerol at a total concentration of 25%. a.Inoculate a single colony of P. aeruginosa YP25-2 into 3 mL of LB liquid medium and incubate at 37°C for 12 h with shaking at 200 × g. Inoculate a single colony of P. aeruginosa YP25-2 into 3 mL of LB liquid medium and incubate at 37°C for 12 h with shaking at 200 × g. b.Transfer the culture at a ratio of 1:100 into 50 mL of LB liquid medium. Transfer the culture at a ratio of 1:100 into 50 mL of LB liquid medium. c.Incubate at 37°C with shaking at 200 × g for 2.5–3.0 h to allow the bacteria to enter the logarithmic growth phase (OD630nm = 0.6). Incubate at 37°C with shaking at 200 × g for 2.5–3.0 h to allow the bacteria to enter the logarithmic growth phase (OD630nm = 0.6). d.Dispense the bacteria into 1.5 mL centrifuge tubes and centrifuge them at 4 °C at 7,000 × g for 5 min, followed by discarding the supernatant. Dispense the bacteria into 1.5 mL centrifuge tubes and centrifuge them at 4 °C at 7,000 × g for 5 min, followed by discarding the supernatant. e.Resuspend the bacteria in 750 μL of sterile ddH2O and centrifuge again at 4 °C at 7,000 × g for 5 min, followed by discarding the supernatant. This process was repeated three times. Resuspend the bacteria in 750 μL of sterile ddH2O and centrifuge again at 4 °C at 7,000 × g for 5 min, followed by discarding the supernatant. This process was repeated three times. f.Store the competent cells of P. aeruginosa YP25-2 at −80°C along with glycerol at a total concentration of 25%. Store the competent cells of P. aeruginosa YP25-2 at −80°C along with glycerol at a total concentration of 25%. Note: Strict control of temperature and rotation speed is imperative during this process to ensure optimal bacterial growth and transformation efficiency. Furthermore, the prepared competent cells must be stored appropriately to prevent contamination and maintain their effectiveness. 8.Electroporation of pCas12aPA and pCRISPR-12a-XXX plasmids into P. aeruginosa YP25-2.a.Add 200 ng of pCasPA-12a plasmid and 200 ng of pCRISPR-12a-XXX plasmid to the 100 μL of P. aeruginosa competent cells prepared above (step 7).b.Transfer the competent cells to a 0.1 mm diameter electroporation cuvette (2100 V, 100 Ω, and 25 μF).c.After electroporation, add 600 μL of antibiotic-free LB liquid medium and incubate on a shaking incubator at 37°C for 2 h.d.Spread 100 μL of the mixture on an LB plate containing 150 μg/mL carbenicillin and 100 μg/mL tetracycline. Electroporation of pCas12aPA and pCRISPR-12a-XXX plasmids into P. aeruginosa YP25-2.a.Add 200 ng of pCasPA-12a plasmid and 200 ng of pCRISPR-12a-XXX plasmid to the 100 μL of P. aeruginosa competent cells prepared above (step 7).b.Transfer the competent cells to a 0.1 mm diameter electroporation cuvette (2100 V, 100 Ω, and 25 μF).c.After electroporation, add 600 μL of antibiotic-free LB liquid medium and incubate on a shaking incubator at 37°C for 2 h.d.Spread 100 μL of the mixture on an LB plate containing 150 μg/mL carbenicillin and 100 μg/mL tetracycline. a.Add 200 ng of pCasPA-12a plasmid and 200 ng of pCRISPR-12a-XXX plasmid to the 100 μL of P. aeruginosa competent cells prepared above (step 7). Add 200 ng of pCasPA-12a plasmid and 200 ng of pCRISPR-12a-XXX plasmid to the 100 μL of P. aeruginosa competent cells prepared above (step 7). b.Transfer the competent cells to a 0.1 mm diameter electroporation cuvette (2100 V, 100 Ω, and 25 μF). Transfer the competent cells to a 0.1 mm diameter electroporation cuvette (2100 V, 100 Ω, and 25 μF). c.After electroporation, add 600 μL of antibiotic-free LB liquid medium and incubate on a shaking incubator at 37°C for 2 h. After electroporation, add 600 μL of antibiotic-free LB liquid medium and incubate on a shaking incubator at 37°C for 2 h. d.Spread 100 μL of the mixture on an LB plate containing 150 μg/mL carbenicillin and 100 μg/mL tetracycline. Spread 100 μL of the mixture on an LB plate containing 150 μg/mL carbenicillin and 100 μg/mL tetracycline. Note: When transferring plasmid DNA into competent cells, ensure that the maximum volume of competent cells does not exceed 200 μL. Validation of cutting efficiency Timing: 2 days Timing: 2 days This section outlines the detailed experimental process for verifying the efficiency of each gRNA in cleaving phage genome, providing reference for subsequent experiments.9.Inoculate P. aeruginosa YP25-2 harboring both pCas12aPA and pCRISPR-12a-XXX plasmids into 5 mL of LB broth containing 150 μg/mL carbenicillin and 100 μg/mL tetracycline.10.Then incubate the cultures in a shaking incubator at 37°C and 200 × g for approximately 3 h until reaching the logarithmic phase (OD630nm = 0.6).11.Add L-arabinose(50 μg/mL), and further induce the cultures for 2–3 h.12.After induction, mix 200 μL of the bacterial suspension with 6 mL of soft LB containing the corresponding antibiotics and arabinose.13.Spot 1 μL with varying dilutions (ranging from 10 to 108 PFU) of phage PJNP029 onto the bacterial plates.5,614.Incubate the plates in a 37°C incubator, and observe the results after 24 h.CRITICAL: To enhance recombination efficiency, it is crucial to store tetracycline away from light and conduct the entire process under light-avoiding conditions.Note: Results showed that phage PJNP029 gRNA-s2, s7, and s8 spacers showed higher cutting efficiency and plating efficiencies of 10–5 to 10–6 (Figure 1). For demonstration purposes, we selected the Ribonucleotide reductase of class Ia encoded by ORF91 of PJNP029 as our subject, conducting gene deletion, point mutation, and gene insertion.Figure 1The cleavage activity with different spacers on phages PJNP029 9.Inoculate P. aeruginosa YP25-2 harboring both pCas12aPA and pCRISPR-12a-XXX plasmids into 5 mL of LB broth containing 150 μg/mL carbenicillin and 100 μg/mL tetracycline. Inoculate P. aeruginosa YP25-2 harboring both pCas12aPA and pCRISPR-12a-XXX plasmids into 5 mL of LB broth containing 150 μg/mL carbenicillin and 100 μg/mL tetracycline. 10.Then incubate the cultures in a shaking incubator at 37°C and 200 × g for approximately 3 h until reaching the logarithmic phase (OD630nm = 0.6). Then incubate the cultures in a shaking incubator at 37°C and 200 × g for approximately 3 h until reaching the logarithmic phase (OD630nm = 0.6). 11.Add L-arabinose(50 μg/mL), and further induce the cultures for 2–3 h. Add L-arabinose(50 μg/mL), and further induce the cultures for 2–3 h. 12.After induction, mix 200 μL of the bacterial suspension with 6 mL of soft LB containing the corresponding antibiotics and arabinose. After induction, mix 200 μL of the bacterial suspension with 6 mL of soft LB containing the corresponding antibiotics and arabinose. 13.Spot 1 μL with varying dilutions (ranging from 10 to 108 PFU) of phage PJNP029 onto the bacterial plates.5,6 Spot 1 μL with varying dilutions (ranging from 10 to 108 PFU) of phage PJNP029 onto the bacterial plates.5,6 14.Incubate the plates in a 37°C incubator, and observe the results after 24 h. Incubate the plates in a 37°C incubator, and observe the results after 24 h. CRITICAL: To enhance recombination efficiency, it is crucial to store tetracycline away from light and conduct the entire process under light-avoiding conditions. Note: Results showed that phage PJNP029 gRNA-s2, s7, and s8 spacers showed higher cutting efficiency and plating efficiencies of 10–5 to 10–6 (Figure 1). For demonstration purposes, we selected the Ribonucleotide reductase of class Ia encoded by ORF91 of PJNP029 as our subject, conducting gene deletion, point mutation, and gene insertion. The cleavage activity with different spacers on phages PJNP029 Construction of plasmids for gene deletion Timing: 4 days Timing: 4 days A homologous region is provided at both ends of a deleted gene to serve as a template for recombination, thereby facilitating the removal of the gene.15.The reaction mixture for PCR amplification was prepared as follows:ReagentsVolume (μL)PrimeSTAR max premix (2 ×)12.5Ygs2qs-tyb1 primer 10.7Ygs2qs-tyb1 primer 20.7Template DNA (10 ng)2Nuclease free water9.1Total2516.Conduct the PCR reaction using the same method described above (step 6).17.Use the Omega Original Adhesive Recycling Kit (Omega, USA) to purify the target DNA.18.Perform overlap PCR amplification using the primers Ygs2qs-tyb1 primer 1 and Ygs2qs-tyb2 primer 2 (see key resources table).19.Digest the plasmids and homologous repair fragments using Xba I and Xho I restriction endonucleases.CRITICAL: The annealing temperature is determined by the Tm value of the primers, and an appropriate annealing temperature is crucial for determining the quality and concentration of the PCR product.20.Mix the following reagents to obtain a 50 μL reaction mixture.ReagentsVolume (μL)Xba I2Xho I210 × M buffer5Plasmid or fragment (200 ng)10Nuclease free water31Total5021.Perform digestion at 37°C for 3 h, and carry out purification using the method described above (step 17).22.Perform the ligation reaction using T4 DNA ligase at 4°C for 12 h.23.Mix the following reagents to obtain a 20 μL reaction mixture.ReagentsVolume (μL)T4 DNA ligase210 × T4 DNA ligase buffer2Plasmid (200 ng)6Insert fragment (200 ng)9Nuclease free water1Total2024.The same method described above is being used to perform heat shock transformation (step 5). 15.The reaction mixture for PCR amplification was prepared as follows: The reaction mixture for PCR amplification was prepared as follows: ReagentsVolume (μL)PrimeSTAR max premix (2 ×)12.5Ygs2qs-tyb1 primer 10.7Ygs2qs-tyb1 primer 20.7Template DNA (10 ng)2Nuclease free water9.1Total25 16.Conduct the PCR reaction using the same method described above (step 6). Conduct the PCR reaction using the same method described above (step 6). 17.Use the Omega Original Adhesive Recycling Kit (Omega, USA) to purify the target DNA. Use the Omega Original Adhesive Recycling Kit (Omega, USA) to purify the target DNA. 18.Perform overlap PCR amplification using the primers Ygs2qs-tyb1 primer 1 and Ygs2qs-tyb2 primer 2 (see key resources table). Perform overlap PCR amplification using the primers Ygs2qs-tyb1 primer 1 and Ygs2qs-tyb2 primer 2 (see key resources table). 19.Digest the plasmids and homologous repair fragments using Xba I and Xho I restriction endonucleases. Digest the plasmids and homologous repair fragments using Xba I and Xho I restriction endonucleases. CRITICAL: The annealing temperature is determined by the Tm value of the primers, and an appropriate annealing temperature is crucial for determining the quality and concentration of the PCR product. 20.Mix the following reagents to obtain a 50 μL reaction mixture. Mix the following reagents to obtain a 50 μL reaction mixture. ReagentsVolume (μL)Xba I2Xho I210 × M buffer5Plasmid or fragment (200 ng)10Nuclease free water31Total50 21.Perform digestion at 37°C for 3 h, and carry out purification using the method described above (step 17). Perform digestion at 37°C for 3 h, and carry out purification using the method described above (step 17). 22.Perform the ligation reaction using T4 DNA ligase at 4°C for 12 h. Perform the ligation reaction using T4 DNA ligase at 4°C for 12 h. 23.Mix the following reagents to obtain a 20 μL reaction mixture. Mix the following reagents to obtain a 20 μL reaction mixture. ReagentsVolume (μL)T4 DNA ligase210 × T4 DNA ligase buffer2Plasmid (200 ng)6Insert fragment (200 ng)9Nuclease free water1Total20 24.The same method described above is being used to perform heat shock transformation (step 5). The same method described above is being used to perform heat shock transformation (step 5). Construction of plasmid for point mutation Timing: 4 days Timing: 4 days This step encompasses the amplification and assembly of homologous regions harboring point mutations, which are utilized as templates for recombination to induce specific gene point mutations.25.Amplify the upstream and downstream homologous arms of the target gene region using the primers Ygs2dtb-tyb1 and Ygs2dtb-tyb2 (see key resources table), respectively.26.Perform overlap PCR using the primers Ygs2dtb-tyb1 primer 1 and Ygs2dtb-tyb2 primer 2 (see key resources table).27.Carry out digestion with Xba I and Xho I restriction endonucleases using the same method described above (steps 19–20). 25.Amplify the upstream and downstream homologous arms of the target gene region using the primers Ygs2dtb-tyb1 and Ygs2dtb-tyb2 (see key resources table), respectively. Amplify the upstream and downstream homologous arms of the target gene region using the primers Ygs2dtb-tyb1 and Ygs2dtb-tyb2 (see key resources table), respectively. 26.Perform overlap PCR using the primers Ygs2dtb-tyb1 primer 1 and Ygs2dtb-tyb2 primer 2 (see key resources table). Perform overlap PCR using the primers Ygs2dtb-tyb1 primer 1 and Ygs2dtb-tyb2 primer 2 (see key resources table). 27.Carry out digestion with Xba I and Xho I restriction endonucleases using the same method described above (steps 19–20). Carry out digestion with Xba I and Xho I restriction endonucleases using the same method described above (steps 19–20). Construction of plasmid for gene insertion Timing: 4 days Timing: 4 days The gene insertion repair plasmid was constructed using the seamless cloning method.7 This step involves the amplification of both homologous regions and insertion fragments, coupled with seamless cloning and assembly, in order to create recombinant templates for gene insertion.28.Acquisition of the insert fragment.a.Amplify the insert gene and its upstream and downstream homologous arms using the upstream and downstream primers of Ygs2cr-tyb1, Ygs2cr-tyb2, Ygs2cr-tyb3, and Ygs2cr-tyb4, respectively (see key resources table).b.Perform overlap PCR using the primers Ygs2cr-tyb1 primer 1 and Ygs2cr-tyb4 primer 2 to obtain the complete fragment.29.Acquisition of the linearized vector. 28.Acquisition of the insert fragment.a.Amplify the insert gene and its upstream and downstream homologous arms using the upstream and downstream primers of Ygs2cr-tyb1, Ygs2cr-tyb2, Ygs2cr-tyb3, and Ygs2cr-tyb4, respectively (see key resources table).b.Perform overlap PCR using the primers Ygs2cr-tyb1 primer 1 and Ygs2cr-tyb4 primer 2 to obtain the complete fragment. Acquisition of the insert fragment.a.Amplify the insert gene and its upstream and downstream homologous arms using the upstream and downstream primers of Ygs2cr-tyb1, Ygs2cr-tyb2, Ygs2cr-tyb3, and Ygs2cr-tyb4, respectively (see key resources table).b.Perform overlap PCR using the primers Ygs2cr-tyb1 primer 1 and Ygs2cr-tyb4 primer 2 to obtain the complete fragment. a.Amplify the insert gene and its upstream and downstream homologous arms using the upstream and downstream primers of Ygs2cr-tyb1, Ygs2cr-tyb2, Ygs2cr-tyb3, and Ygs2cr-tyb4, respectively (see key resources table). Amplify the insert gene and its upstream and downstream homologous arms using the upstream and downstream primers of Ygs2cr-tyb1, Ygs2cr-tyb2, Ygs2cr-tyb3, and Ygs2cr-tyb4, respectively (see key resources table). b.Perform overlap PCR using the primers Ygs2cr-tyb1 primer 1 and Ygs2cr-tyb4 primer 2 to obtain the complete fragment. Perform overlap PCR using the primers Ygs2cr-tyb1 primer 1 and Ygs2cr-tyb4 primer 2 to obtain the complete fragment. 29.Acquisition of the linearized vector. Acquisition of the linearized vector. Digest the pCRISPR-12a-s2 plasmid with Xba I and Xho I restriction endonucleases to obtain the linearized vector.30.Seamless cloning reaction system.a.According to the instructions of the ClonExpress Ultra One Step Cloning Kit (Vazyme, Nanjing, China).b.Mix the following reagents to obtain a 10 μL reaction mixture.ReagentsVolume (μL)Linearized vector (50 ng)3Insert fragment (200 ng)0.52 × CE mix5Nuclease free water1.5Total10c.After mixing the system, incubate it at 50°C for 5 min and then cool it to 4°C or immediately place on ice.d.Heat-shock transform the product into DH5α competent cells, using the same method described above (step 5).Note: The amount of linearized vector and insert fragment added may vary depending on their concentrations. Please refer to the kit instructions for specific calculation methods. 30.Seamless cloning reaction system.a.According to the instructions of the ClonExpress Ultra One Step Cloning Kit (Vazyme, Nanjing, China).b.Mix the following reagents to obtain a 10 μL reaction mixture.ReagentsVolume (μL)Linearized vector (50 ng)3Insert fragment (200 ng)0.52 × CE mix5Nuclease free water1.5Total10c.After mixing the system, incubate it at 50°C for 5 min and then cool it to 4°C or immediately place on ice.d.Heat-shock transform the product into DH5α competent cells, using the same method described above (step 5).Note: The amount of linearized vector and insert fragment added may vary depending on their concentrations. Please refer to the kit instructions for specific calculation methods. Seamless cloning reaction system.a.According to the instructions of the ClonExpress Ultra One Step Cloning Kit (Vazyme, Nanjing, China).b.Mix the following reagents to obtain a 10 μL reaction mixture.ReagentsVolume (μL)Linearized vector (50 ng)3Insert fragment (200 ng)0.52 × CE mix5Nuclease free water1.5Total10c.After mixing the system, incubate it at 50°C for 5 min and then cool it to 4°C or immediately place on ice.d.Heat-shock transform the product into DH5α competent cells, using the same method described above (step 5).Note: The amount of linearized vector and insert fragment added may vary depending on their concentrations. Please refer to the kit instructions for specific calculation methods. a.According to the instructions of the ClonExpress Ultra One Step Cloning Kit (Vazyme, Nanjing, China). According to the instructions of the ClonExpress Ultra One Step Cloning Kit (Vazyme, Nanjing, China). b.Mix the following reagents to obtain a 10 μL reaction mixture.ReagentsVolume (μL)Linearized vector (50 ng)3Insert fragment (200 ng)0.52 × CE mix5Nuclease free water1.5Total10 Mix the following reagents to obtain a 10 μL reaction mixture.ReagentsVolume (μL)Linearized vector (50 ng)3Insert fragment (200 ng)0.52 × CE mix5Nuclease free water1.5Total10 ReagentsVolume (μL)Linearized vector (50 ng)3Insert fragment (200 ng)0.52 × CE mix5Nuclease free water1.5Total10 c.After mixing the system, incubate it at 50°C for 5 min and then cool it to 4°C or immediately place on ice. After mixing the system, incubate it at 50°C for 5 min and then cool it to 4°C or immediately place on ice. d.Heat-shock transform the product into DH5α competent cells, using the same method described above (step 5).Note: The amount of linearized vector and insert fragment added may vary depending on their concentrations. Please refer to the kit instructions for specific calculation methods. Heat-shock transform the product into DH5α competent cells, using the same method described above (step 5).Note: The amount of linearized vector and insert fragment added may vary depending on their concentrations. Please refer to the kit instructions for specific calculation methods. Note: The amount of linearized vector and insert fragment added may vary depending on their concentrations. Please refer to the kit instructions for specific calculation methods. Phage infection Timing: 2 days Timing: 2 days This section describes the procedure of phage infection, by which mutant phages are acquired.31.Mix the P. aeruginosa YP25-2 cells (without any plasmids) in exponential growth phase (OD630nm = 0.6) with purified wild-type phage PJNP029 at a multiplicity of infection (MOI) of 0.1 and then incubate them at 37°C for 12 h.32.Calculate the titers of phage PJNP029 by performing serial ten-fold dilutions in sterile SM buffer.8,933.200 μL of P. aeruginosa YP25-2 (contained plasmids: pCas12aPA and pCRISPR-12a-XXX) and 6 mL of soft LB agar containing 150 μg/mL carbenicillin and 100 μg/mL tetracycline, and 50 μg/mL L-arabinose with ∼108 PFU phage PJNP029 poured on the lower layer LB medium and then incubate them at 37°C for 12 h. 31.Mix the P. aeruginosa YP25-2 cells (without any plasmids) in exponential growth phase (OD630nm = 0.6) with purified wild-type phage PJNP029 at a multiplicity of infection (MOI) of 0.1 and then incubate them at 37°C for 12 h. Mix the P. aeruginosa YP25-2 cells (without any plasmids) in exponential growth phase (OD630nm = 0.6) with purified wild-type phage PJNP029 at a multiplicity of infection (MOI) of 0.1 and then incubate them at 37°C for 12 h. 32.Calculate the titers of phage PJNP029 by performing serial ten-fold dilutions in sterile SM buffer.8,9 Calculate the titers of phage PJNP029 by performing serial ten-fold dilutions in sterile SM buffer.8,9 33.200 μL of P. aeruginosa YP25-2 (contained plasmids: pCas12aPA and pCRISPR-12a-XXX) and 6 mL of soft LB agar containing 150 μg/mL carbenicillin and 100 μg/mL tetracycline, and 50 μg/mL L-arabinose with ∼108 PFU phage PJNP029 poured on the lower layer LB medium and then incubate them at 37°C for 12 h. 200 μL of P. aeruginosa YP25-2 (contained plasmids: pCas12aPA and pCRISPR-12a-XXX) and 6 mL of soft LB agar containing 150 μg/mL carbenicillin and 100 μg/mL tetracycline, and 50 μg/mL L-arabinose with ∼108 PFU phage PJNP029 poured on the lower layer LB medium and then incubate them at 37°C for 12 h. Isolation of phage mutants Timing: 1 week Timing: 1 week This step entails the isolation of mutant phages, followed by incubation and serial propagation to guarantee robust replication of phage plaques.34.Preparation of experimental materials.a.A-200 μL aliquot of exponential phase (OD630nm = 0.6) P. aeruginosa YP25-2 was cultured.b.Mix 6 mL of soft LB agar and then pour onto the lower layer of LB medium as described above (step 33).35.Initial phage plaque isolation.a.Use sterilized toothpicks to pick 10 random phage plaques from the double-layer agar plates and transfer them to 10 μL of sterile SM buffer.b.Then spot these plaques onto fresh double-layer agar plates for further propagation.36.Incubation and serial propagation.a.Incubate the plates at 37°C for 12 h to allow phage plaque growth.b.On the second day, use sterilized toothpicks to individually pick each phage plaque and spot onto the double-layer agar plates.10c.Repeat this step for at least three consecutive generations to ensure robust phage plaque propagation.11Note: This step requires strict operation to prevent cross contamination of phage mutants. 34.Preparation of experimental materials.a.A-200 μL aliquot of exponential phase (OD630nm = 0.6) P. aeruginosa YP25-2 was cultured.b.Mix 6 mL of soft LB agar and then pour onto the lower layer of LB medium as described above (step 33). Preparation of experimental materials.a.A-200 μL aliquot of exponential phase (OD630nm = 0.6) P. aeruginosa YP25-2 was cultured.b.Mix 6 mL of soft LB agar and then pour onto the lower layer of LB medium as described above (step 33). a.A-200 μL aliquot of exponential phase (OD630nm = 0.6) P. aeruginosa YP25-2 was cultured. A-200 μL aliquot of exponential phase (OD630nm = 0.6) P. aeruginosa YP25-2 was cultured. b.Mix 6 mL of soft LB agar and then pour onto the lower layer of LB medium as described above (step 33). Mix 6 mL of soft LB agar and then pour onto the lower layer of LB medium as described above (step 33). 35.Initial phage plaque isolation.a.Use sterilized toothpicks to pick 10 random phage plaques from the double-layer agar plates and transfer them to 10 μL of sterile SM buffer.b.Then spot these plaques onto fresh double-layer agar plates for further propagation. Initial phage plaque isolation.a.Use sterilized toothpicks to pick 10 random phage plaques from the double-layer agar plates and transfer them to 10 μL of sterile SM buffer.b.Then spot these plaques onto fresh double-layer agar plates for further propagation. a.Use sterilized toothpicks to pick 10 random phage plaques from the double-layer agar plates and transfer them to 10 μL of sterile SM buffer. Use sterilized toothpicks to pick 10 random phage plaques from the double-layer agar plates and transfer them to 10 μL of sterile SM buffer. b.Then spot these plaques onto fresh double-layer agar plates for further propagation. Then spot these plaques onto fresh double-layer agar plates for further propagation. 36.Incubation and serial propagation.a.Incubate the plates at 37°C for 12 h to allow phage plaque growth.b.On the second day, use sterilized toothpicks to individually pick each phage plaque and spot onto the double-layer agar plates.10c.Repeat this step for at least three consecutive generations to ensure robust phage plaque propagation.11 Incubation and serial propagation.a.Incubate the plates at 37°C for 12 h to allow phage plaque growth.b.On the second day, use sterilized toothpicks to individually pick each phage plaque and spot onto the double-layer agar plates.10c.Repeat this step for at least three consecutive generations to ensure robust phage plaque propagation.11 a.Incubate the plates at 37°C for 12 h to allow phage plaque growth. Incubate the plates at 37°C for 12 h to allow phage plaque growth. b.On the second day, use sterilized toothpicks to individually pick each phage plaque and spot onto the double-layer agar plates.10 On the second day, use sterilized toothpicks to individually pick each phage plaque and spot onto the double-layer agar plates.10 c.Repeat this step for at least three consecutive generations to ensure robust phage plaque propagation.11 Repeat this step for at least three consecutive generations to ensure robust phage plaque propagation.11 Note: This step requires strict operation to prevent cross contamination of phage mutants. Detection and examination of the genotype of phage mutants Timing: 4 days Timing: 4 days This step includes the details of using PCR detection and Sanger sequencing for the screening of positive clones.Note: Extract genomic DNA from each purified putative recombinant phages. Then perform PCR amplification using wild-type PJNP029 phage-specific primers to identify and select positive clones for further analysis.37.Successfully delete 408 bp fragment of the Ribonucleotide reductase of class Ia gene in the phage (Figure 2A). PCR amplification of possible phage mutants revealed 100% (n = 10) positive clones (Figure 2B), and observe phage plaques on the plate (Figure 2C).38.Sanger sequencing of the PCR amplifications unequivocally confirmed the successful base editing, yielding an impressive editing efficiency of 100% (n = 10), as depicted in Figure 3.39.We inserted a 1071-bp target gene fused with homology arms of ∼500 bp. PCR amplification of the possible recombinant PJNP029 phage showed 100% (n = 10) positive clones (Figure 4). Sanger sequencing of the PCR amplification products confirmed the success of the base editing (Figure 4).Figure 2The CRISPR-Cas12a system mediates efficient gene deletion in phage(A) Sanger sequencing of the target gene.(B) Amplified PCR product. “+” represents the wild-type phage, numbers 1–10 designate potential recombinant phages, and “_” denotes the negative control.(C) Phage plaque was observed on the plate compared to WT strain.Figure 3Detection of point mutation of target geneFigure 4Detection of inserted gene Note: Extract genomic DNA from each purified putative recombinant phages. Then perform PCR amplification using wild-type PJNP029 phage-specific primers to identify and select positive clones for further analysis. 37.Successfully delete 408 bp fragment of the Ribonucleotide reductase of class Ia gene in the phage (Figure 2A). PCR amplification of possible phage mutants revealed 100% (n = 10) positive clones (Figure 2B), and observe phage plaques on the plate (Figure 2C). Successfully delete 408 bp fragment of the Ribonucleotide reductase of class Ia gene in the phage (Figure 2A). PCR amplification of possible phage mutants revealed 100% (n = 10) positive clones (Figure 2B), and observe phage plaques on the plate (Figure 2C). 38.Sanger sequencing of the PCR amplifications unequivocally confirmed the successful base editing, yielding an impressive editing efficiency of 100% (n = 10), as depicted in Figure 3. Sanger sequencing of the PCR amplifications unequivocally confirmed the successful base editing, yielding an impressive editing efficiency of 100% (n = 10), as depicted in Figure 3. 39.We inserted a 1071-bp target gene fused with homology arms of ∼500 bp. PCR amplification of the possible recombinant PJNP029 phage showed 100% (n = 10) positive clones (Figure 4). Sanger sequencing of the PCR amplification products confirmed the success of the base editing (Figure 4). We inserted a 1071-bp target gene fused with homology arms of ∼500 bp. PCR amplification of the possible recombinant PJNP029 phage showed 100% (n = 10) positive clones (Figure 4). Sanger sequencing of the PCR amplification products confirmed the success of the base editing (Figure 4). The CRISPR-Cas12a system mediates efficient gene deletion in phage (A) Sanger sequencing of the target gene. (B) Amplified PCR product. “+” represents the wild-type phage, numbers 1–10 designate potential recombinant phages, and “_” denotes the negative control. (C) Phage plaque was observed on the plate compared to WT strain. Detection of point mutation of target gene Detection of inserted gene Expected outcomes The deliberate modification of native phages to suit clinical applications has emerged as a focal point of research in this field. Recombinant phages hold promise for potential applications in phage therapy, offering novel avenues for treating bacterial infections. This study establishes a method for editing the genome of the PJNP029 phage using the type V CRISPR-Cas12a system, enabling efficient gene deletions, point mutations, and gene insertions. Our research unequivocally demonstrates the remarkable efficacy of the type V CRISPR-Cas12a gene editing technique, achieving a 100% success rate in targeted gene deletions, point mutations, and gene insertions within the PJNP029 phage genome. By harnessing this gene editing technology, we can precisely manipulate the phage genome to enhance its therapeutic properties, broaden its host range, or confer resistance to environmental factors, thereby optimizing its performance in phage therapy. Furthermore, the ability to introduce specific genetic modifications into the PJNP029 phage genome opens up new possibilities for developing targeted therapies against antibiotic-resistant bacteria. For instance, by inserting genes encoding enzymes that degrade bacterial biofilms or enhancing the phage’s lytic activity, we can create recombinant phages with enhanced antibacterial efficacy. Additionally, gene deletions or point mutations can be employed to attenuate the phage’s virulence, making it safer for use in humans while maintaining its ability to infect and kill target bacteria. In conclusion, our study establishes a robust method for engineering the PJNP029 phage genome using the type V CRISPR-Cas12a system, demonstrating its high efficiency in achieving targeted genetic modifications. This significant advancement paves the way for deeper exploration of recombinant phages in the realm of phage therapy, holding immense potential to revolutionize the treatment landscape for bacterial infections, especially those caused by challenging antibiotic-resistant strains. Future research will focus on evaluating the efficacy and safety of these engineered phages in preclinical models, paving the way for their translation into clinical practice.12,13,14 Limitations Previous research has indicated that, within P. aeruginosa phages, the type V CRISPR-Cas12a system exhibits higher gene editing efficiency compared to the type II CRISPR-Cas9 system. This finding underscores the potential benefits of utilizing the CRISPR-Cas12a system for gene manipulation in these phages. However, it is crucial to acknowledge that different spacers may affect the cutting efficiency of the CRISPR-Cas12a system, implying that spacer selection could be a pivotal factor in optimizing gene editing results. At present, it is unclear whether this specific phage harbors any anti-Cas12a proteins, which could potentially disrupt the gene editing process. Additional research is warranted to explore this possibility and to comprehensively grasp the potential challenges and constraints of employing the CRISPR-Cas12a system in P. aeruginosa phages. Troubleshooting Problem 1 No single colony growth observed on the resistant plate (step 8). Potential solution Increase the concentration of the transferred recombinant plasmids while elevating the concentration and viability of competent cells to promote the growth of single colonies on the resistant plate . Problem 2 The targeted gRNA lacks activity (steps 9–14). Potential solution Given that the cleavage efficiency of gRNA can differ across various gene loci, one potential solution involves selecting and experimenting with an alternative gRNA positioned at a different location on the same gene. Problem 3 Low concentration of homologous arm fragments obtained (steps 15–16). Potential solution Adjust the annealing temperature of the PCR program appropriately based on the G + C content of the primers, and moderately increase the number of cycles in the amplification process to enhance the concentration of the obtained homologous arm fragments. Problem 4 Low efficiency in constructing recombinant plasmids (steps 20–24). Potential solution Increase the recovery concentration of the target fragments and vectors after enzyme digestion to improve the efficiency of recombinant plasmid construction. Problem 5 CRISPR-Cas12a might prove ineffective in operating within certain P. aeruginosa host bacteria (steps 9–14). Potential solution The genome of the P. aeruginosa host bacterium should be selected for testing, and an assessment should be made to predict the presence of any anti-CRISPR-associated proteins. Resource availability Lead contact Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Yibao Chen (yibaochen2012@126.com). Technical contact Questions about the technical specifics of performing the protocol should be directed to and will be answered by the technical contacts, Bingjie Yan (yanbingjie0107@163.com) and Yibao Chen (yibaochen2012@126.com). Materials availability All unique/stable reagents in this study are available from the lead contact without restriction. Data and code availability The complete genome sequence of phage PJNP029 with annotation has been deposited in GenBank under accession number OR941787. Acknowledgments This study was funded by the National Key Research and Development Project (2019YFA0904003 and 2023YFE0107600), National Natural Science Foundation of China (32402982), the Innovation Capability Improvement Project for Science and Technology SMEs in Shandong Province (2022TSGC2384), the Shandong Provincial Natural Science Foundation (ZR2022QC028), the Agricultural Scientific and Technological Innovation Project of Shandong Academy of Agricultural Sciences (CXGC2022E10; CXGC2023F10), Taishan/Quancheng Industry Leader (tscy20231201), and the Shandong province Modern Agricultural Industrial system (SDAIT-11-09). Author contributions B.Y. and Y. Chen drafted the main manuscript and performed the data analysis; B.Y. and Yujia Liu planned and performed experiments; Y. Cai, Yuqing Liu, and Y. Chen were responsible for the experimental design. All authors reviewed and agreed to the publication of this manuscript. Declaration of interests The authors declare no competing interests.